PepGen Inc. (PEPG)
5.505
-1.26
(-18.57%)
USD |
NASDAQ |
Mar 05, 16:00
5.70
+0.20
(+3.54%)
After-Hours: 07:48
PepGen Cash from Investing (Quarterly) : -66.24M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.001M |
| Ekso Bionics Holdings, Inc. | -0.126M |
| Climb Bio, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.84M |
| Cash from Financing (Quarterly) | -0.171M |
| Free Cash Flow | -81.90M |
| Free Cash Flow Per Share (Quarterly) | -0.2303 |
| Free Cash Flow to Equity (Quarterly) | -15.41M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -35.30% |